Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Chubb
Merck
McKesson
Julphar
Dow
Cipla
Harvard Business School

Generated: November 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017031

« Back to Dashboard

NDA 017031 describes OPILL, which is a drug marketed by Laboratoire Hra and is included in one NDA. Additional details are available on the OPILL profile page.

The generic ingredient in OPILL is norgestrel. There are twenty-five drug master file entries for this compound. Additional details are available on the norgestrel profile page.
Summary for 017031
Tradename:OPILL
Applicant:Laboratoire Hra
Ingredient:norgestrel
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017031

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.075MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 017031

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Laboratoire Hra OPILL norgestrel TABLET;ORAL 017031-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Laboratoire Hra OPILL norgestrel TABLET;ORAL 017031-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Laboratoire Hra OPILL norgestrel TABLET;ORAL 017031-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fuji
Medtronic
Deloitte
Harvard Business School
Mallinckrodt
Accenture
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.